Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncology Injection Drug
1.2 Key Market Segments
1.2.1 Oncology Injection Drug Segment by Type
1.2.2 Oncology Injection Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncology Injection Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Oncology Injection Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology Injection Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncology Injection Drug Market Competitive Landscape
3.1 Global Oncology Injection Drug Sales by Manufacturers (2019-2024)
3.2 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Injection Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Injection Drug Sales Sites, Area Served, Product Type
3.6 Oncology Injection Drug Market Competitive Situation and Trends
3.6.1 Oncology Injection Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Injection Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncology Injection Drug Industry Chain Analysis
4.1 Oncology Injection Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncology Injection Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncology Injection Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Injection Drug Sales Market Share by Type (2019-2024)
6.3 Global Oncology Injection Drug Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Injection Drug Price by Type (2019-2024)
7 Oncology Injection Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Injection Drug Market Sales by Application (2019-2024)
7.3 Global Oncology Injection Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Injection Drug Sales Growth Rate by Application (2019-2024)
8 Oncology Injection Drug Market Segmentation by Region
8.1 Global Oncology Injection Drug Sales by Region
8.1.1 Global Oncology Injection Drug Sales by Region
8.1.2 Global Oncology Injection Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Injection Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Injection Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Injection Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Injection Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Injection Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Taj Oncology
9.1.1 Taj Oncology Oncology Injection Drug Basic Information
9.1.2 Taj Oncology Oncology Injection Drug Product Overview
9.1.3 Taj Oncology Oncology Injection Drug Product Market Performance
9.1.4 Taj Oncology Business Overview
9.1.5 Taj Oncology Oncology Injection Drug SWOT Analysis
9.1.6 Taj Oncology Recent Developments
9.2 S.G. Biopharm
9.2.1 S.G. Biopharm Oncology Injection Drug Basic Information
9.2.2 S.G. Biopharm Oncology Injection Drug Product Overview
9.2.3 S.G. Biopharm Oncology Injection Drug Product Market Performance
9.2.4 S.G. Biopharm Business Overview
9.2.5 S.G. Biopharm Oncology Injection Drug SWOT Analysis
9.2.6 S.G. Biopharm Recent Developments
9.3 AdvaCare
9.3.1 AdvaCare Oncology Injection Drug Basic Information
9.3.2 AdvaCare Oncology Injection Drug Product Overview
9.3.3 AdvaCare Oncology Injection Drug Product Market Performance
9.3.4 AdvaCare Oncology Injection Drug SWOT Analysis
9.3.5 AdvaCare Business Overview
9.3.6 AdvaCare Recent Developments
9.4 Merrimack
9.4.1 Merrimack Oncology Injection Drug Basic Information
9.4.2 Merrimack Oncology Injection Drug Product Overview
9.4.3 Merrimack Oncology Injection Drug Product Market Performance
9.4.4 Merrimack Business Overview
9.4.5 Merrimack Recent Developments
9.5 Celgene
9.5.1 Celgene Oncology Injection Drug Basic Information
9.5.2 Celgene Oncology Injection Drug Product Overview
9.5.3 Celgene Oncology Injection Drug Product Market Performance
9.5.4 Celgene Business Overview
9.5.5 Celgene Recent Developments
9.6 Allos Therapeutics
9.6.1 Allos Therapeutics Oncology Injection Drug Basic Information
9.6.2 Allos Therapeutics Oncology Injection Drug Product Overview
9.6.3 Allos Therapeutics Oncology Injection Drug Product Market Performance
9.6.4 Allos Therapeutics Business Overview
9.6.5 Allos Therapeutics Recent Developments
9.7 Ferring Pharmaceuticals
9.7.1 Ferring Pharmaceuticals Oncology Injection Drug Basic Information
9.7.2 Ferring Pharmaceuticals Oncology Injection Drug Product Overview
9.7.3 Ferring Pharmaceuticals Oncology Injection Drug Product Market Performance
9.7.4 Ferring Pharmaceuticals Business Overview
9.7.5 Ferring Pharmaceuticals Recent Developments
9.8 Genzyme
9.8.1 Genzyme Oncology Injection Drug Basic Information
9.8.2 Genzyme Oncology Injection Drug Product Overview
9.8.3 Genzyme Oncology Injection Drug Product Market Performance
9.8.4 Genzyme Business Overview
9.8.5 Genzyme Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Oncology Injection Drug Basic Information
9.9.2 Eli Lilly Oncology Injection Drug Product Overview
9.9.3 Eli Lilly Oncology Injection Drug Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 Praecis Pharmaceuticals
9.10.1 Praecis Pharmaceuticals Oncology Injection Drug Basic Information
9.10.2 Praecis Pharmaceuticals Oncology Injection Drug Product Overview
9.10.3 Praecis Pharmaceuticals Oncology Injection Drug Product Market Performance
9.10.4 Praecis Pharmaceuticals Business Overview
9.10.5 Praecis Pharmaceuticals Recent Developments
9.11 Millennium Pharmaceuticals
9.11.1 Millennium Pharmaceuticals Oncology Injection Drug Basic Information
9.11.2 Millennium Pharmaceuticals Oncology Injection Drug Product Overview
9.11.3 Millennium Pharmaceuticals Oncology Injection Drug Product Market Performance
9.11.4 Millennium Pharmaceuticals Business Overview
9.11.5 Millennium Pharmaceuticals Recent Developments
9.12 Debiopharm
9.12.1 Debiopharm Oncology Injection Drug Basic Information
9.12.2 Debiopharm Oncology Injection Drug Product Overview
9.12.3 Debiopharm Oncology Injection Drug Product Market Performance
9.12.4 Debiopharm Business Overview
9.12.5 Debiopharm Recent Developments
9.13 Alza
9.13.1 Alza Oncology Injection Drug Basic Information
9.13.2 Alza Oncology Injection Drug Product Overview
9.13.3 Alza Oncology Injection Drug Product Market Performance
9.13.4 Alza Business Overview
9.13.5 Alza Recent Developments
9.14 CordenPharma
9.14.1 CordenPharma Oncology Injection Drug Basic Information
9.14.2 CordenPharma Oncology Injection Drug Product Overview
9.14.3 CordenPharma Oncology Injection Drug Product Market Performance
9.14.4 CordenPharma Business Overview
9.14.5 CordenPharma Recent Developments
9.15 Pharmascience
9.15.1 Pharmascience Oncology Injection Drug Basic Information
9.15.2 Pharmascience Oncology Injection Drug Product Overview
9.15.3 Pharmascience Oncology Injection Drug Product Market Performance
9.15.4 Pharmascience Business Overview
9.15.5 Pharmascience Recent Developments
10 Oncology Injection Drug Market Forecast by Region
10.1 Global Oncology Injection Drug Market Size Forecast
10.2 Global Oncology Injection Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Injection Drug Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Injection Drug Market Size Forecast by Region
10.2.4 South America Oncology Injection Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Injection Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Oncology Injection Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology Injection Drug by Type (2025-2030)
11.1.2 Global Oncology Injection Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology Injection Drug by Type (2025-2030)
11.2 Global Oncology Injection Drug Market Forecast by Application (2025-2030)
11.2.1 Global Oncology Injection Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Oncology Injection Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
